GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (XTER:EWL) » Definitions » Cyclically Adjusted Price-to-FCF

Edwards Lifesciences (XTER:EWL) Cyclically Adjusted Price-to-FCF : 55.06 (As of Jun. 02, 2025)


View and export this data going back to 1990. Start your Free Trial

What is Edwards Lifesciences Cyclically Adjusted Price-to-FCF?

As of today (2025-06-02), Edwards Lifesciences's current share price is €68.83. Edwards Lifesciences's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was €1.25. Edwards Lifesciences's Cyclically Adjusted Price-to-FCF for today is 55.06.

The historical rank and industry rank for Edwards Lifesciences's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

XTER:EWL' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 41.98   Med: 72.27   Max: 113.15
Current: 55.92

During the past years, Edwards Lifesciences's highest Cyclically Adjusted Price-to-FCF was 113.15. The lowest was 41.98. And the median was 72.27.

XTER:EWL's Cyclically Adjusted Price-to-FCF is ranked worse than
67.21% of 247 companies
in the Medical Devices & Instruments industry
Industry Median: 36.39 vs XTER:EWL: 55.92

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Edwards Lifesciences's adjusted free cash flow per share data for the three months ended in Mar. 2025 was €0.353. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is €1.25 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Edwards Lifesciences Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Edwards Lifesciences's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edwards Lifesciences Cyclically Adjusted Price-to-FCF Chart

Edwards Lifesciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 97.20 108.59 54.10 52.26 54.70

Edwards Lifesciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 66.48 69.07 47.39 54.70 51.82

Competitive Comparison of Edwards Lifesciences's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Edwards Lifesciences's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Edwards Lifesciences's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Edwards Lifesciences's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Edwards Lifesciences's Cyclically Adjusted Price-to-FCF falls into.


;
;

Edwards Lifesciences Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Edwards Lifesciences's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=68.83/1.25
=55.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Edwards Lifesciences's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Edwards Lifesciences's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.353/134.9266*134.9266
=0.353

Current CPI (Mar. 2025) = 134.9266.

Edwards Lifesciences Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 0.205 100.684 0.275
201509 0.238 100.392 0.320
201512 0.087 99.792 0.118
201603 0.109 100.470 0.146
201606 0.153 101.688 0.203
201609 0.215 101.861 0.285
201612 0.200 101.863 0.265
201703 0.158 102.862 0.207
201706 0.187 103.349 0.244
201709 0.356 104.136 0.461
201712 0.398 104.011 0.516
201803 0.132 105.290 0.169
201806 0.117 106.317 0.148
201809 0.345 106.507 0.437
201812 0.325 105.998 0.414
201903 -0.080 107.251 -0.101
201906 0.375 108.070 0.468
201909 0.515 108.329 0.641
201912 0.468 108.420 0.582
202003 0.178 108.902 0.221
202006 0.176 108.767 0.218
202009 0.152 109.815 0.187
202012 0.367 109.897 0.451
202103 0.259 111.754 0.313
202106 0.602 114.631 0.709
202109 0.634 115.734 0.739
202112 0.392 117.630 0.450
202203 0.318 121.301 0.354
202206 0.436 125.017 0.471
202209 0.404 125.227 0.435
202212 0.297 125.222 0.320
202303 0.366 127.348 0.388
202306 -0.022 128.729 -0.023
202309 0.548 129.860 0.569
202312 0.073 129.419 0.076
202403 -0.211 131.776 -0.216
202406 0.440 132.554 0.448
202409 0.444 133.029 0.450
202412 -0.294 133.157 -0.298
202503 0.353 134.927 0.353

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Edwards Lifesciences  (XTER:EWL) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Edwards Lifesciences Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Edwards Lifesciences's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Edwards Lifesciences Business Description

Address
One Edwards Way, Irvine, CA, USA, 92614
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.